Porcine Health Management

Chosen Topics:

Immunology and Vaccinology

16 - 30 of 44

IN VITRO CHARACTERIZATION OF PRRSV ISOLATES WITH DIFFERENT IN VIVO PATHOGENICITY BY USING MONOCYTE-DERIVED MACROPHAGES.

Porcine reproductive and respiratory syndrome virus (PRRSV) is classified in two genotypes: type 1 and type 2. Within these two genotypes, several isolates exist with different virulence and pathogenicity features. Recently, highly pathogenic (HP)...
Type
Abstract
Year
2018
Topic
Immunology and Vaccinology
Affiliation
UNIPR-Department of Veterinary Science

EFFECT OF ID AND IM ADMINISTRATION OF A PRRSV MLV VACCINE IN PIGLETS ON APOPTOSIS-RELATED SERUM BIOMARKERS

PRRSV-infection can induce cell apoptosis both in vivo and in vitro. Soluble Fas-sFas/APO-1 is an inhibitor of apoptosis, while angiotensin II (AT-II) plays an essential role in the apoptosis. This study investigated the ID and IM administration of a...
Type
Abstract
Year
2018
Topic
Immunology and Vaccinology
Affiliation
FACULTY OF VETERINARY MEDICINE, UNIVERSITY OF THESSALY

FIELD EVALUATION OF ID AND IM PRRSV MLV VACCINATION IN SUCKLING PIGLETS ON HEALTH AND PERFORMANCE

PRRSV vaccination is a potential strategy to reduce not only the virus shedding, but also the severity of respiratory signs of growing/finishing pigs. This field study evaluated the ID and IM vaccination in suckling piglets. <strong>Material &...
Type
Abstract
Year
2018
Topic
Immunology and Vaccinology
Affiliation
FACULTY OF VETERINARY MEDICINE, UNIVERSITY OF THESSALY

DEVELOPMENT OF A MONOVALENT PIG VACCINE BASED ON A HUMAN PANDEMIC H1N1 (2009) STRAIN  

Immediately after initial emergence in humans in 2009, pandemic H1N1 has now spread globally and represents a thread for global pig production by inducing economic losses worldwide. Based on a human virus isolate from 2009, IDT Biologika developed an...
Type
Abstract
Year
2018
Topic
Immunology and Vaccinology
Affiliation
IDT Biologika GmbH

EFFICACY OF RESPIPORC® FLUPAN H1N1 UNDER FIELD CONDITIONS

Due the lack of an efficacious vaccine against the globally spreading pandemic subtype of Influenza A virus in swine, IDT Biologika developed an inactivated full virus vaccine for use in pigs based on a human pandemic virus isolate from 2009. Proof of...
Type
Abstract
Year
2018
Topic
Immunology and Vaccinology
Affiliation
IDT Biologika GmbH

EVALUATION OF THE GENETIC DIVERSITY OF H1PDM INFLUENZA FIELD VIRUSES IN RESPECT TO RESPIPORC® FLUPAN H1N1

Since the emergence of pandemic H1N1 Influenza virus in the swine population in 2009 this subtype has established itself as endemic in swine. In contrast to pandemic H1N1 variant isolates in humans, which hardly undergo any change genetically, the swine...
Type
Abstract
Year
2018
Topic
Immunology and Vaccinology
Affiliation
IDT Biologika GmbH

SAFETY PROFILE OF THE NEWLY REGISTERED SWINE INFLUENZA VACCINE RESPIPORC® FLUPAN H1N1

Since the emergence of pandemic H1N1 in 2009, this subtype has become endemic in pigs. European Pharmacopoeia requires inter alia safety profile to gain market authorisation in Europe. Balance between broad efficacy and excellent safety is crucial in...
Type
Abstract
Year
2018
Topic
Immunology and Vaccinology
Affiliation
IDT Biologika GmbH

SIGNIFICANT REDUCTION OF PCV2-VIRAEMIA AND IMPROVEMENT OF PRODUCTION PARAMETERS DURING FATTENING FOLLOWING VACCINATION WITH A READY-TO-USE PCV MHYO...

In order to improve animal welfare and production processes, one-shot vaccines that are as effective as separate vaccination schemes, have been developed. The aim of the field trial was to compare efficacy of a combination PCV-Mhyo vaccine against another...
Type
Abstract
Year
2018
Topic
Immunology and Vaccinology
Affiliation
MSD Animal Health

DEVELOPMENT A POTENTIAL IMMUNOGENIC RECOMBINANT HEMAGGLUTININ-NEURAMINIDASE PROTEIN OF PORCINE RUBULAVIRUS

Blue eye disease caused by <i>Porcine rubulavirus </i>(PorPV) is an endemic viral infection of swine causing neurological and respiratory disease in piglets, and reproductive failure in sows and boars. The hemagglutinin-neuraminidase (HN) glycoprotein of...
Type
Abstract
Year
2018
Topic
Immunology and Vaccinology
Affiliation
INIFAP

SAFETY OF VEPURED® VACCINE IN TWO DAY OLD PIGLETS  

The aim of this study was to evaluate the safety of VEPURED® under laboratory and field conditions.   Material & Methods Laboratory study: Twenty-six healthy 2-day old piglets were randomly assigned to 2 groups. The piglets were either vaccinated...
Type
Abstract
Year
2018
Topic
Immunology and Vaccinology
Affiliation
HIPRA

CHEMICAL CLARIFICATION OF ORAL FLUIDS DOES NOT AFFECT PRRSV IGG ELISA

Routine surveillance using individual animal samples (serum, nasal swabs) is labor intensive and expensive.  In contrast, oral fluids are easily collected and welfare-friendly.  However, oral fluid often contains feed, feces, and other undesirable...
Type
Abstract
Year
2018
Topic
Immunology and Vaccinology
Affiliation
Iowa State University

REDUCTION OF THE PREVALENCE OF BORDETELLA BRONCHISEPTICA INFECTION IN PIGLETS AFTER SOW VACCINATION

Vaccination is one of the methods used for the prevention of bacterial diseases in domestic animals. Although non-progressive atrophic rhinitis (NPAR) caused by <i>Bordetella bronchiseptica</i> (Bb) is endemic in commercial pigs, little information about...
Type
Abstract
Year
2018
Topic
Immunology and Vaccinology
Affiliation
HIPRA

EVALUATION OF THE EFFECT OF UNISTRAIN VACCINATION BY SERUMPROFILING AND ANTIBIOTIC USAGE.

At a Dutch farm a recurrent respiratory problem appeared in the weaned piglets of 6 - 8 weeks. Clinical signs were coughing and diminished growth. Antibiotics were used to relieve clinical signs.  Diagnosis was made by a serumprofile, collecting blood in...
Type
Abstract
Year
2018
Topic
Immunology and Vaccinology
Affiliation
Hipra

FIELD EXPERIENCE WITH AN INTRANASAL MUCOSAL PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS VACCINE DURING AN ACTIVE PRRSV BREAK

Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) remains to be one of the major pathogens in the swine industry worldwide.  Recently an intranasal (IN) mucosal autogenous PRRSV vaccine, Barricade® PRRS has been made available. The objective...
Type
Abstract
Year
2018
Topic
Immunology and Vaccinology
Affiliation
Aptimmune; 19575 Middle Rd,

NO INFLUENCE OF MATERNAL ANTIBODIES ON PIGLET SEROLOGICAL IGM RESPONSE TO PCV2 VACCINATION

Several field cases in the Netherlands showed varying proportions of PCV2-IgM positive piglets at 3-5 weeks post vaccination (pv) with Ingelvac CircoFLEX (CF). A possible explanation for the variation in serological IgM results pv is the level of maternal...
Type
Abstract
Year
2018
Topic
Immunology and Vaccinology
Affiliation
Boehringer Ingelheim AH Netherlands